Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...

The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (CT03767348) trial in advanced melanoma was not ...

Fingal County Council has declared a planning application by the National Transport Authority for a ‘strategic’ park-and-ride ...

Replimune, which was seeking approval of RP1 in combination with Bristol Myers Squibb's Opdivo for the treatment of advanced melanoma, on Tuesday said the FDA issued a so-called complete response ...

Candidates are advised to apply well before the deadline and carefully follow all application instructions, as incomplete or ...

Martin Lewis is urging older people to check if they qualify for a little-known benefit that could boost their income by over ...

Purple Biotech Ltd. ('Purple Biotech' or 'the Company') (NASDAQ/TASE: PPBT), a clinical-stage company developing ...

Shares fell 75% to $3.04, putting the stock on track for a record closing low, according to Dow Jones Market Data. The stock ...

In 2022, the DWP discovered several State Pension cases where it seemed that historical periods of Home Responsibilities ...

The Defence Research and Development Laboratory (DRDL), Hyderabad is a premier laboratory of the Defence Research and ...

DHAKA, July 15, 2025 (BSS) - The Ministry of Religious Affairs has sought application from authorized agencies to participate ...

So, here are six tell-tale ways to make sure recruiters know (or at least think) your grad job application was actually ...